Given that breast cancer is a highly heterogeneous disease with a great degree of lineage plasticity, we posit that knockdown of LSD1 could target more differentiated luminal cell populations for cell death and consequently enrich for a side population that is more susceptible to dedifferentiate into a stem-like/basal-like state. This evidence concerns the gene KDM1A and breast carcinoma.